Both in Pharmaceuticals
Valion Bio vs Karyopharm Therapeutics
Over the past year VBIO returned −77.1% and KPTI returned −95.5%; their daily moves had a correlation of -0.05.
VBIO −77.1% KPTI −95.5%Growth of $1, one year, split-adjusted
| Metric | VBIO | KPTI |
|---|---|---|
| Price | $0.5171 | $0.0729 |
| Market cap | $1.1M | $1.7M |
| Today | −2.60% | −17.44% |
| 1 month | −78.3% | −88.8% |
| 6 months | — | −99.2% |
| Year to date | — | −99.0% |
| 1 year | — | −98.8% |
| Revenue growth (YoY) | — | −11.9% |
| Gross margin | — | 96.8% |
| Net margin | — | −200.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.0× |
| Net cash | -$5.3M | -$184.8M |
| Dividend yield | — | — |
| Volatility (60d) | — | 413.8% |
| Short % of float | 9.0% | 34.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).